Steatel (levocarnitine) oral solution 1 g/10 ml. vials №10

Description

Steatel (levocarnitine) oral solution 1 g/10 ml. vials №10 

Composition

active substance: levocarnitine;

1 ml of solution contains 100 mg of levocarnitine;

Excipients: malic acid, methylparaben (E 218), propylparaben (E 216), sodium saccharin, flavoring “orange”, purified water.

Dosage form

The solution is oral.

Basic physical and chemical properties: clear liquid from colorless to yellowish color.

Pharmacotherapeutic group

Amino acids and their derivatives.
ATX code A16A A01.

Pharmacological properties

This drug belongs to the group of amino acids or vitamin-like substances based on levocarnitine.
The main active ingredient, levocarnitine, or L-carnitine, is naturally produced independently by the human liver, kidneys and brain tissue, using amino acids such as lysine and methionine, as well as iron and ascorbic acid preparations.

Levocarnitine is the main cofactor in the metabolism of fatty acids in the muscles of the heart, skeleton and liver, therefore it is recommended for athletes. Plays important roles in other metabolic processes of the body, increases concentration.

It is able to remove metabolites and toxins from the cytoplasm, improves metabolism, including in hyperthyroidism. As a result, it helps to increase efficiency, accelerate growth, and increase muscle mass.
Due to the presence of levocarnitine, symptoms of both physical and mental stress are reduced, and it has neuroprotective, hepatoprotective and cardioprotective effects.

Reduces ischemia of the heart muscle, the amount of cholesterol in the blood. It has the property of stimulating the immune system of cells, helps to eliminate functional disorders of the nervous system in patients with alcoholism, with withdrawal symptoms.

Indications

This drug Steatel solution is used to treat:

• primary (congenital) carnitine deficiency;
• secondary deficiency of carnitine caused by congenital metabolic disorders.

It is also prescribed for suspected secondary carnitine deficiency in patients undergoing hemodialysis for:

• severe persistent muscle spasms and / or hypotensive episodes during dialysis;
• energy deficiency, which leads to a significant negative impact on the quality of life;
• muscle weakness and / or myopathy;
• cardiopathy;
• anemia that does not respond to erythropoietin treatment or requires high doses of erythropoietin;
• loss of muscle mass.

Contraindications

Not applicable if the patient has hypersensitivity (allergy) to one of the components that make up the drug.

Application during pregnancy and lactation

Not used for the treatment of pregnant women (except in cases of absolute necessity).
If there is a need to take this drug, then lactation (breastfeeding) should be suspended during treatment.

Method of application and dosage

Doses and duration of treatment are determined by the doctor individually depending on the age and nosological form of the disease. Steatel solution taken orally 30 minutes before eating. Use a dosing syringe or measuring cup to dispense the drug. Adults should be prescribed the drug in an initial dose of 1 g per day (10 ml), gradually increasing the dose depending on the patient’s condition and tolerability. The usual dose of the drug for adults is 1-3 g (10-30 ml) per day, divided into 1-3 doses. The maximum daily dose for adults is 6 g (60 ml).

The average course of treatment for adults and children is 1-3 months. If necessary, the course of treatment can be repeated. In the case of primary and secondary carnitine deficiency, the drug should be taken constantly or until the cause of the latter is eliminated.

Children

The drug Steatel solution should be used in children (full-term and premature infants) from the first day of life.

Steatel solution should be prescribed to children starting with a dose of 50 mg / kg per day. The usual doses for children are 50-100 mg / kg per day.

The maximum daily dose for children is 3 g (30 ml).

Overdose

There are no cases of drug overdose at the moment.
If taken too much, diarrhea is possible. Treatment of symptoms, gastric lavage, and intake of enterosorbents is recommended.

Side effects

Therapy with this drug can cause side reactions in the form of:

• allergic reactions;
• dyspeptic disorders;
• pain in the epigastrium;
• nausea, vomiting;
• may cause stomach reaction as a laxative;
• seizures, convulsive seizures (in those suffering from seizures – more frequent seizures).

If you have any unusual side effects as a result of taking this drug, you should consult your doctor about possible changes in the treatment regimen.